{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:27:54Z","timestamp":1773160074191,"version":"3.50.1"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Fonds de recherche Sant\u00e9 Qu\u00e9bec"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0\u20130.05 cases\/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0\u20134.06 cases\/100 person-years).<\/jats:p>","DOI":"10.1093\/cid\/ciz048","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T15:26:30Z","timestamp":1547479590000},"page":"869-872","source":"Crossref","is-referenced-by-count":28,"title":["Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation"],"prefix":"10.1093","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-2063","authenticated-orcid":false,"given":"Matthew P","family":"Cheng","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda E","family":"Kusztos","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler D","family":"Bold","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital"},{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent T","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett E","family":"Glotzbecker","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan A","family":"Baker","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey R","family":"Baden","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4271-7443","authenticated-orcid":false,"given":"Sarah P","family":"Hammond","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-8734","authenticated-orcid":false,"given":"Francisco M","family":"Marty","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"2019123108582265100_CIT0001","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1164\/rccm.2508001","article-title":"Controlling tuberculosis in the United States","volume":"172","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2019123108582265100_CIT0002","first-page":"1091","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"key":"2019123108582265100_CIT0003","article-title":"Diagnosis of latent tuberculosis infection","author":"Pai","year":"2014","edition":"7"},{"key":"2019123108582265100_CIT0004","doi-asserted-by":"crossref","first-page":"ciw838","DOI":"10.1093\/cid\/ciw838","article-title":"Risk of active tuberculosis in patients with cancer: a systematic review and meta-analysis","volume":"64","author":"Cheng","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019123108582265100_CIT0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","author":"Menzies","year":"2018","journal-title":"N Engl J Med"},{"key":"2019123108582265100_CIT0006","doi-asserted-by":"crossref","first-page":"e12794","DOI":"10.1111\/tid.12794","article-title":"Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation","volume":"20","author":"Agrawal","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2019123108582265100_CIT0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2018.07.001","article-title":"Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: a cohort study in a high endemic area","volume-title":"J Microbiol Immunol Infect","author":"Liu","year":"2018"},{"key":"2019123108582265100_CIT0008","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5588\/ijtld.14.0301","article-title":"Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study","volume":"19","author":"Fan","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019123108582265100_CIT0009","first-page":"572","article-title":"Tuberculosis morbidity in the US Navy: its distribution and decline","volume":"110","author":"Comstock","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"2019123108582265100_CIT0010","doi-asserted-by":"crossref","first-page":"k2738","DOI":"10.1136\/bmj.k2738","article-title":"Revisiting the timetable of tuberculosis","volume":"362","author":"Behr","year":"2018","journal-title":"BMJ"},{"key":"2019123108582265100_CIT0011","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-\u03b3 release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/5\/869\/31666418\/ciz048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/5\/869\/31666418\/ciz048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T08:58:57Z","timestamp":1577782737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/5\/869\/5303791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":11,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,3,28]]},"published-print":{"date-parts":[[2019,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz048","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9,1]]},"published":{"date-parts":[[2019,3,28]]}}}